ESTRADIOL,

ESTRADIOL, was reported 86535 times

These side effects are most commonly reported by patients taking ESTRADIOL,:

# Side effect Count
0 DRUG INEFFECTIVE 3821
1 HEADACHE 2879
2 NAUSEA 2873
3 FATIGUE 2868
4 OFF LABEL USE 2394
5 PAIN 2077
6 DIARRHOEA 1953
7 DIZZINESS 1723
8 BREAST CANCER FEMALE 1708
9 ARTHRALGIA 1633
10 PRURITUS 1558
11 PRODUCT ADHESION ISSUE 1536
12 RASH 1535
13 DYSPNOEA 1524
14 VOMITING 1344
15 INSOMNIA 1340
16 PRODUCT DOSE OMISSION ISSUE 1256
17 MALAISE 1253
18 DEVICE ADHESION ISSUE 1249
19 HOT FLUSH 1242
20 ANXIETY 1240
21 FEELING ABNORMAL 1118
22 DEPRESSION 1091
23 PAIN IN EXTREMITY 1086
24 ASTHENIA 1051
25 WEIGHT INCREASED 993
26 FALL 978
27 CONDITION AGGRAVATED 914
28 COUGH 908
29 BACK PAIN 892
30 WEIGHT DECREASED 863
31 PRODUCT USE IN UNAPPROVED INDICATION 848
32 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 848
33 MUSCLE SPASMS 819
34 INJECTION SITE PAIN 815
35 ALOPECIA 808
36 URINARY TRACT INFECTION 800
37 ABDOMINAL PAIN 782
38 MIGRAINE 781
39 PRODUCT QUALITY ISSUE 753
40 SINUSITIS 748
41 CONSTIPATION 742
42 HYPERSENSITIVITY 729
43 PNEUMONIA 713
44 ABDOMINAL PAIN UPPER 711
45 COVID-19 705
46 DRUG HYPERSENSITIVITY 704
47 PARAESTHESIA 683
48 HYPERTENSION 671
49 PRODUCT USE ISSUE 665
50 PYREXIA 663
51 ABDOMINAL DISCOMFORT 661
52 INCORRECT DOSE ADMINISTERED 654
53 URTICARIA 650
54 DRUG INTERACTION 640
55 GAIT DISTURBANCE 639
56 CHEST PAIN 625
57 DEVICE MALFUNCTION 623
58 BREAST CANCER 613
59 HYPERHIDROSIS 595
60 MYALGIA 591
61 PALPITATIONS 590
62 NASOPHARYNGITIS 581
63 HYPOAESTHESIA 570
64 ABDOMINAL DISTENSION 547
65 SOMNOLENCE 542
66 TREMOR 539
67 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 536
68 BLOOD PRESSURE INCREASED 534
69 PERIPHERAL SWELLING 534
70 VISION BLURRED 533
71 DECREASED APPETITE 521
72 ERYTHEMA 519
73 MEMORY IMPAIRMENT 517
74 PRODUCT SUBSTITUTION ISSUE 478
75 ASTHMA 474
76 PRODUCT PACKAGING ISSUE 473
77 BRONCHITIS 470
78 GASTROOESOPHAGEAL REFLUX DISEASE 463
79 APPLICATION SITE ERYTHEMA 457
80 CHRONIC KIDNEY DISEASE 455
81 APPLICATION SITE PRURITUS 441
82 ILLNESS 434
83 CONTUSION 428
84 JOINT SWELLING 425
85 NO ADVERSE EVENT 421
86 EYE PAIN 420
87 MUSCULAR WEAKNESS 415
88 CHEST DISCOMFORT 413
89 DEVICE ISSUE 408
90 DYSPEPSIA 404
91 FLUSHING 396
92 SUICIDAL IDEATION 393
93 OEDEMA PERIPHERAL 388
94 PSORIASIS 387
95 OROPHARYNGEAL PAIN 386
96 ACUTE KIDNEY INJURY 385
97 HEART RATE INCREASED 377
98 NIGHT SWEATS 377
99 INJECTION SITE ERYTHEMA 368
100 INFECTION 367
101 BALANCE DISORDER 365
102 VISUAL IMPAIRMENT 365
103 RHEUMATOID ARTHRITIS 362
104 SLEEP DISORDER 360
105 EYE IRRITATION 358
106 DRY MOUTH 354
107 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 353
108 CHILLS 349
109 DEHYDRATION 348
110 APPLICATION SITE RASH 346
111 STRESS 346
112 DRUG INTOLERANCE 345
113 BURNING SENSATION 344
114 DRY SKIN 339
115 INFLUENZA 339
116 RENAL FAILURE 334
117 HYPOTENSION 333
118 VAGINAL HAEMORRHAGE 333
119 CONFUSIONAL STATE 332
120 SWELLING 326
121 ARTHRITIS 320
122 INFLUENZA LIKE ILLNESS 320
123 DRY EYE 316
124 LOSS OF CONSCIOUSNESS 313
125 DEATH 310
126 GASTROINTESTINAL DISORDER 308
127 ANAEMIA 303
128 DRUG DOSE OMISSION 293
129 FEELING HOT 291
130 PULMONARY EMBOLISM 291
131 NECK PAIN 284
132 SWELLING FACE 283
133 CEREBROVASCULAR ACCIDENT 277
134 INTENTIONAL PRODUCT USE ISSUE 275
135 DISCOMFORT 272
136 NEUROPATHY PERIPHERAL 270
137 VERTIGO 269
138 OSTEOARTHRITIS 268
139 FUNGAL INFECTION 266
140 DEPRESSED MOOD 264
141 OSTEOPOROSIS 263
142 MUSCULOSKELETAL STIFFNESS 259
143 DYSGEUSIA 256
144 APPLICATION SITE IRRITATION 255
145 IRRITABILITY 250
146 MENOPAUSAL SYMPTOMS 248
147 MATERNAL EXPOSURE DURING PREGNANCY 247
148 UPPER RESPIRATORY TRACT INFECTION 246
149 AMNESIA 245
150 DISEASE RECURRENCE 244
151 HEPATIC ENZYME INCREASED 244
152 TINNITUS 241
153 PRODUCT USE COMPLAINT 239
154 SURGERY 239
155 MENINGIOMA 238
156 INJECTION SITE BRUISING 235
157 HAEMORRHAGE 233
158 DYSPHAGIA 231
159 DYSPHONIA 229
160 ADVERSE DRUG REACTION 224
161 SKIN EXFOLIATION 224
162 DISTURBANCE IN ATTENTION 223
163 PRODUCT PHYSICAL ISSUE 222
164 INJECTION SITE PRURITUS 221
165 RASH PRURITIC 221
166 RHINORRHOEA 219
167 NASAL CONGESTION 218
168 APPLICATION SITE PAIN 213
169 BONE PAIN 213
170 DIVERTICULITIS 213
171 BLOOD GLUCOSE INCREASED 212
172 SEIZURE 210
173 THERAPY INTERRUPTED 210
174 UNEVALUABLE EVENT 210
175 VULVOVAGINAL BURNING SENSATION 210
176 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 208
177 SYNCOPE 207
178 THERAPEUTIC PRODUCT EFFECT DECREASED 207
179 BLISTER 206
180 ATRIAL FIBRILLATION 205
181 HAEMOGLOBIN DECREASED 203
182 DERMATITIS ATOPIC 202
183 RASH ERYTHEMATOUS 202
184 NERVOUSNESS 201
185 WHEEZING 201
186 CRYING 199
187 ECZEMA 197
188 MYOCARDIAL INFARCTION 197
189 PRODUCT DOSE OMISSION 197
190 MOBILITY DECREASED 196
191 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 196
192 HERPES ZOSTER 194
193 INJECTION SITE SWELLING 194
194 CATARACT 193
195 WHITE BLOOD CELL COUNT DECREASED 193
196 DEVICE DIFFICULT TO USE 192
197 INTENTIONAL PRODUCT MISUSE 192
198 MULTIPLE SCLEROSIS RELAPSE 192
199 PRODUCT AVAILABILITY ISSUE 192
200 INJECTION SITE REACTION 190
201 FLATULENCE 189
202 OEDEMA 189
203 OVERDOSE 189
204 BLOOD CHOLESTEROL INCREASED 188
205 DEEP VEIN THROMBOSIS 188
206 PSORIATIC ARTHROPATHY 188
207 TREATMENT FAILURE 187
208 TACHYCARDIA 186
209 LETHARGY 185
210 CROHN^S DISEASE 183
211 NEPHROLITHIASIS 183
212 PRODUCT PACKAGING QUANTITY ISSUE 182
213 ELECTROCARDIOGRAM QT PROLONGED 181
214 TOXICITY TO VARIOUS AGENTS 181
215 HALLUCINATION 180
216 SKIN IRRITATION 179
217 THERAPY CESSATION 179
218 AGITATION 176
219 FIBROMYALGIA 175
220 SLEEP APNOEA SYNDROME 175
221 ARTHROPATHY 172
222 PANIC ATTACK 172
223 THERAPEUTIC RESPONSE UNEXPECTED 172
224 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 172
225 CYSTITIS 171
226 ABORTION SPONTANEOUS 170
227 CARDIAC DISORDER 169
228 VULVOVAGINAL DISCOMFORT 169
229 ADVERSE EVENT 168
230 DRUG LEVEL INCREASED 168
231 EMOTIONAL DISTRESS 168
232 SKIN BURNING SENSATION 168
233 FLUID RETENTION 167
234 HOSPITALISATION 167
235 MUSCULOSKELETAL PAIN 167
236 INCORRECT DOSE ADMINISTERED BY DEVICE 166
237 UNDERDOSE 166
238 LIMB DISCOMFORT 163
239 LIP SWELLING 162
240 THROAT IRRITATION 161
241 HYSTERECTOMY 158
242 COGNITIVE DISORDER 157
243 POLLAKIURIA 157
244 THYROID DISORDER 157
245 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 156
246 EYE SWELLING 156
247 OCULAR HYPERAEMIA 156
248 CARDIAC FAILURE CONGESTIVE 154
249 INFLAMMATION 153
250 MOOD SWINGS 153
251 SCHIZOAFFECTIVE DISORDER 153
252 CELLULITIS 152
253 INFUSION RELATED REACTION 151
254 SPEECH DISORDER 151
255 ACCIDENTAL EXPOSURE TO PRODUCT 150
256 DRUG-INDUCED LIVER INJURY 150
257 MULTIPLE SCLEROSIS 150
258 POOR QUALITY SLEEP 150
259 BREAST TENDERNESS 149
260 BRAIN FOG 148
261 ANAPHYLACTIC REACTION 147
262 THROMBOSIS 147
263 DRUG EFFECT DECREASED 146
264 IRRITABLE BOWEL SYNDROME 146
265 PANCREATITIS 145
266 STOMATITIS 145
267 DEVICE DEFECTIVE 144
268 DIABETES MELLITUS 144
269 GENERAL PHYSICAL HEALTH DETERIORATION 143
270 PRODUCTIVE COUGH 143
271 URINARY INCONTINENCE 143
272 WITHDRAWAL SYNDROME 143
273 BLOOD POTASSIUM DECREASED 142
274 ROAD TRAFFIC ACCIDENT 141
275 EPISTAXIS 140
276 LOWER RESPIRATORY TRACT INFECTION 140
277 SKIN REACTION 138
278 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 136
279 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 135
280 NEURALGIA 135
281 GLAUCOMA 134
282 RASH PAPULAR 133
283 CANDIDA INFECTION 132
284 THERAPY NON-RESPONDER 132
285 ANGER 131
286 INJURY 131
287 RASH MACULAR 131
288 RESTLESS LEGS SYNDROME 131
289 GAIT INABILITY 130
290 INJECTION SITE HAEMORRHAGE 130
291 PRODUCT ADMINISTRATION ERROR 130
292 SKIN DISCOLOURATION 130
293 SWOLLEN TONGUE 130
294 DERMATITIS CONTACT 129
295 DYSPNOEA EXERTIONAL 129
296 MEDICATION ERROR 129
297 NIGHTMARE 128
298 ORAL HERPES 127
299 POSTMENOPAUSAL HAEMORRHAGE 127
300 BREAST PAIN 126
301 DEPRESSED LEVEL OF CONSCIOUSNESS 126
302 IMPAIRED GASTRIC EMPTYING 126
303 PLATELET COUNT DECREASED 126
304 ACNE 125
305 PRODUCT DOSE OMISSION IN ERROR 125
306 PRODUCT STORAGE ERROR 125
307 SYSTEMIC LUPUS ERYTHEMATOSUS 125
308 BLOOD PRESSURE DECREASED 124
309 C-REACTIVE PROTEIN INCREASED 124
310 DISORIENTATION 124
311 LACRIMATION INCREASED 122
312 COLITIS 121
313 VIRAL INFECTION 121
314 CHOLELITHIASIS 120
315 CONTRAINDICATED PRODUCT ADMINISTERED 120
316 ILL-DEFINED DISORDER 120
317 EAR PAIN 119
318 GASTRIC DISORDER 119
319 SEPSIS 119
320 TRANSIENT ISCHAEMIC ATTACK 119
321 TREATMENT NONCOMPLIANCE 119
322 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 118
323 DRUG WITHDRAWAL SYNDROME 118
324 INTENTIONAL DOSE OMISSION 118
325 HIATUS HERNIA 117
326 INTERVERTEBRAL DISC PROTRUSION 117
327 MIDDLE INSOMNIA 117
328 SYNOVITIS 117
329 TOXIC EPIDERMAL NECROLYSIS 117
330 OSTEOPENIA 116
331 SEASONAL ALLERGY 116
332 THERAPEUTIC RESPONSE DECREASED 116
333 LYMPHADENOPATHY 115
334 SKIN DISORDER 115
335 VAGINAL DISCHARGE 115
336 VULVOVAGINAL DRYNESS 115
337 DEVICE BREAKAGE 114
338 GASTRITIS 114
339 THERAPEUTIC RESPONSE SHORTENED 114
340 DYSKINESIA 113
341 HORMONE LEVEL ABNORMAL 113
342 IMPAIRED HEALING 113
343 MOVEMENT DISORDER 112
344 RECTAL HAEMORRHAGE 112
345 VULVOVAGINAL PRURITUS 112
346 DYSARTHRIA 111
347 INTESTINAL OBSTRUCTION 111
348 MOOD ALTERED 111
349 PAIN IN JAW 111
350 HEAD INJURY 110
351 FOOT FRACTURE 109
352 OXYGEN SATURATION DECREASED 109
353 FEELING COLD 108
354 HEART RATE DECREASED 108
355 INJECTION SITE RASH 108
356 SINUS DISORDER 108
357 APHASIA 107
358 DYSURIA 107
359 EMOTIONAL DISORDER 107
360 LIMB INJURY 107
361 ALANINE AMINOTRANSFERASE INCREASED 106
362 EAR INFECTION 106
363 RENAL IMPAIRMENT 106
364 COLITIS MICROSCOPIC 105
365 HAEMATOCHEZIA 105
366 VULVOVAGINAL PAIN 105
367 ASPARTATE AMINOTRANSFERASE INCREASED 102
368 EYE PRURITUS 102
369 HYPOACUSIS 102
370 MENTAL DISORDER 102
371 HYPERSOMNIA 101
372 PHOTOPHOBIA 100
373 DEVICE DELIVERY SYSTEM ISSUE 99
374 DIPLOPIA 99
375 WHITE BLOOD CELL COUNT INCREASED 99
376 HYPONATRAEMIA 97
377 HYPOTHYROIDISM 97
378 IMPAIRED WORK ABILITY 97
379 INTERVERTEBRAL DISC DEGENERATION 97
380 SUICIDE ATTEMPT 97
381 WRONG TECHNIQUE IN DRUG USAGE PROCESS 97
382 ARRHYTHMIA 96
383 EYE DISORDER 96
384 HEPATIC CIRRHOSIS 96
385 INTERMENSTRUAL BLEEDING 96
386 SCAR 96
387 SCIATICA 96
388 SPINAL OSTEOARTHRITIS 95
389 JOINT STIFFNESS 94
390 RESPIRATORY DEPRESSION 94
391 RESTLESSNESS 94
392 STAPHYLOCOCCAL INFECTION 94
393 HAEMORRHOIDS 93
394 POOR QUALITY PRODUCT ADMINISTERED 93
395 ABNORMAL DREAMS 92
396 DISEASE PROGRESSION 92
397 DRUG DOSE OMISSION BY DEVICE 92
398 EXPOSURE DURING PREGNANCY 92
399 PRODUCT ADMINISTRATION INTERRUPTED 92
400 RESPIRATORY TRACT INFECTION 92
401 HYPOKALAEMIA 91
402 INJECTION SITE URTICARIA 91
403 NEUTROPENIA 91
404 RENAL INJURY 91
405 THROAT TIGHTNESS 91
406 THROMBOCYTOPENIA 91
407 APPLICATION SITE VESICLES 90
408 DEVICE USE ISSUE 90
409 EXPIRED PRODUCT ADMINISTERED 90
410 FEELING JITTERY 90
411 LUNG DISORDER 90
412 PROCEDURAL PAIN 90
413 INFUSION SITE PAIN 89
414 INSURANCE ISSUE 89
415 PRODUCT PRESCRIBING ERROR 88
416 CONVULSION 87
417 END STAGE RENAL DISEASE 87
418 INJECTION SITE MASS 87
419 EXPOSURE VIA SKIN CONTACT 86
420 FOETAL EXPOSURE DURING PREGNANCY 86
421 PHARMACEUTICAL PRODUCT COMPLAINT 86
422 ADHESIVE TAPE USE 85
423 BLOOD OESTROGEN DECREASED 85
424 CARPAL TUNNEL SYNDROME 85
425 FEEDING DISORDER 85
426 LIVER DISORDER 85
427 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 85
428 SYMPTOM RECURRENCE 85
429 TYPE 2 DIABETES MELLITUS 85
430 MENTAL IMPAIRMENT 84
431 CHRONIC SINUSITIS 83
432 DYSSTASIA 83
433 EMPHYSEMA 83
434 HEPATOTOXICITY 83
435 JOINT INJURY 83
436 PRE-EXISTING CONDITION IMPROVED 83
437 COLITIS ULCERATIVE 82
438 COMPLETED SUICIDE 82
439 IMPAIRED QUALITY OF LIFE 82
440 NEOPLASM MALIGNANT 82
441 RENAL DISORDER 82
442 DIVERTICULUM 81
443 GASTROINTESTINAL HAEMORRHAGE 81
444 INFUSION SITE ERYTHEMA 81
445 RESPIRATORY DISORDER 81
446 GLOSSODYNIA 80
447 THERAPEUTIC PRODUCT INEFFECTIVE 80
448 TRICUSPID VALVE INCOMPETENCE 80
449 BLOOD CREATININE INCREASED 79
450 MANIA 79
451 PARAESTHESIA ORAL 79
452 ROTATOR CUFF SYNDROME 79
453 LIVER FUNCTION TEST ABNORMAL 78
454 MUSCLE TWITCHING 78
455 NERVOUS SYSTEM DISORDER 78
456 RESPIRATORY TRACT CONGESTION 78
457 TOOTHACHE 78
458 EATING DISORDER 77
459 HEAD DISCOMFORT 77
460 PELVIC PAIN 77
461 TASTE DISORDER 77
462 ABDOMINAL PAIN LOWER 76
463 CHROMATURIA 76
464 FEAR 76
465 MULTIPLE ALLERGIES 76
466 PAIN OF SKIN 76
467 PLEURAL EFFUSION 76
468 PRODUCT PRESCRIBING ISSUE 76
469 PSYCHOTIC DISORDER 76
470 ABNORMAL BEHAVIOUR 75
471 ANGIOEDEMA 75
472 ANKLE FRACTURE 75
473 BREAST CANCER METASTATIC 75
474 COELIAC DISEASE 75
475 IRON DEFICIENCY ANAEMIA 75
476 KIDNEY INFECTION 75
477 ORAL PAIN 75
478 VITAMIN D DEFICIENCY 75
479 AGEUSIA 74
480 DRUG EFFECT INCOMPLETE 74
481 KNEE ARTHROPLASTY 74
482 PANCREATITIS ACUTE 74
483 PRESYNCOPE 74
484 APPLICATION SITE REACTION 73
485 BLOOD PRESSURE FLUCTUATION 73
486 BURSITIS 73
487 FREQUENT BOWEL MOVEMENTS 73
488 HEART RATE IRREGULAR 73
489 LOWER LIMB FRACTURE 73
490 MUSCULOSKELETAL DISCOMFORT 73
491 PHOTOSENSITIVITY REACTION 73
492 THINKING ABNORMAL 73
493 BLINDNESS 72
494 SKIN LESION 72
495 SNEEZING 72
496 AGGRESSION 71
497 CLOSTRIDIUM DIFFICILE INFECTION 71
498 MUSCLE TIGHTNESS 71
499 SINUS CONGESTION 71
500 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71
501 UPPER LIMB FRACTURE 71
502 WOUND 71
503 DRUG EFFECT LESS THAN EXPECTED 70
504 MICTURITION URGENCY 70
505 NEEDLE ISSUE 70
506 RIB FRACTURE 70
507 TOOTH INFECTION 70
508 BLOOD PRESSURE SYSTOLIC INCREASED 69
509 DISABILITY 69
510 ECONOMIC PROBLEM 69
511 LOCALISED INFECTION 69
512 OVARIAN CANCER 69
513 SPINAL OPERATION 69
514 THIRST 69
515 HYPERLIPIDAEMIA 68
516 PRODUCT INEFFECTIVE 68
517 PRODUCT SOLUBILITY ABNORMAL 68
518 RASH GENERALISED 68
519 SKIN CANCER 68
520 URINARY RETENTION 68
521 ACTIVITIES OF DAILY LIVING IMPAIRED 67
522 BLOOD PRESSURE ABNORMAL 67
523 BONE DISORDER 67
524 DRUG DEPENDENCE 67
525 HIP FRACTURE 67
526 MACULOPATHY 67
527 OESTROGEN RECEPTOR ASSAY POSITIVE 67
528 POST PROCEDURAL COMPLICATION 67
529 SENSORY DISTURBANCE 67
530 SKIN FISSURES 67
531 BRADYCARDIA 66
532 DEVICE PHYSICAL PROPERTY ISSUE 66
533 EPILEPSY 66
534 EXOSTOSIS 66
535 INJECTION SITE WARMTH 66
536 OCULAR DISCOMFORT 66
537 BLOOD TRIGLYCERIDES INCREASED 65
538 COLITIS ISCHAEMIC 65
539 HAIR GROWTH ABNORMAL 65
540 MOUTH ULCERATION 65
541 OVARIAN CYST 65
542 ANGINA PECTORIS 64
543 GASTROENTERITIS VIRAL 64
544 ORAL DISCOMFORT 64
545 RHABDOMYOLYSIS 64
546 AUTOIMMUNE DISORDER 63
547 DEAFNESS 63
548 ERUCTATION 63
549 NASAL POLYPS 63
550 PRODUCT DISPENSING ERROR 63
551 PRURITUS GENERALISED 63
552 TENDONITIS 63
553 TUBULOINTERSTITIAL NEPHRITIS 63
554 APPLICATION SITE BURN 62
555 GLYCOSYLATED HAEMOGLOBIN INCREASED 62
556 NEPHROGENIC ANAEMIA 62
557 BLOOD GLUCOSE DECREASED 61
558 BLOOD SODIUM DECREASED 61
559 CHOKING 61
560 DEVICE LEAKAGE 61
561 LIGAMENT SPRAIN 61
562 MUSCULOSKELETAL CHEST PAIN 61
563 NERVE INJURY 61
564 OVARIAN HYPERSTIMULATION SYNDROME 61
565 PRODUCT COMPLAINT 61
566 ANHEDONIA 60
567 EMBOLISM VENOUS 60
568 FEMUR FRACTURE 60
569 GASTROENTERITIS 60
570 HYPOPHAGIA 60
571 INCREASED APPETITE 60
572 PRODUCT PACKAGING DIFFICULT TO OPEN 60
573 TENDERNESS 60
574 VAGINAL INFECTION 60
575 BONE DENSITY DECREASED 59
576 COLD SWEAT 59
577 HYPERTHYROIDISM 59
578 PRODUCT RESIDUE PRESENT 59
579 PULMONARY OEDEMA 59
580 RED BLOOD CELL COUNT DECREASED 59
581 RETCHING 59
582 SKIN ULCER 59
583 TOOTH DISORDER 59
584 BACK DISORDER 58
585 BODY TEMPERATURE INCREASED 58
586 BREAST MASS 58
587 DIASTOLIC DYSFUNCTION 58
588 HEPATIC STEATOSIS 58
589 OBSTRUCTIVE AIRWAYS DISORDER 58
590 ORAL CANDIDIASIS 58
591 POOR QUALITY DEVICE USED 58
592 RESPIRATORY FAILURE 58
593 SMALL INTESTINAL OBSTRUCTION 58
594 TEMPERATURE INTOLERANCE 58
595 BODY HEIGHT DECREASED 57
596 ENDOMETRIOSIS 57
597 HEPATIC ENCEPHALOPATHY 57
598 HYPOGLYCAEMIA 57
599 INFUSION SITE SWELLING 57
600 LOCAL SWELLING 57
601 PRODUCT ODOUR ABNORMAL 57
602 ABASIA 56
603 BLOOD ALKALINE PHOSPHATASE INCREASED 56
604 CORONARY ARTERY DISEASE 56
605 GASTRIC ULCER 56
606 LARYNGITIS 56
607 MENTAL STATUS CHANGES 56
608 PHARYNGEAL OEDEMA 56
609 RENAL PAIN 56
610 SKIN LACERATION 56
611 COORDINATION ABNORMAL 55
612 DERMATITIS 55
613 FACIAL PAIN 55
614 HAEMATOCRIT DECREASED 55
615 IMMUNODEFICIENCY 55
616 LEUKOPENIA 55
617 PREMATURE BABY 55
618 TENDON RUPTURE 55
619 FAECES DISCOLOURED 54
620 FEMALE GENITAL TRACT FISTULA 54
621 INITIAL INSOMNIA 54
622 REBOUND ACID HYPERSECRETION 54
623 RENAL FAILURE ACUTE 54
624 APATHY 53
625 BACTERIAL INFECTION 53
626 BLOOD OESTROGEN INCREASED 53
627 CONJUNCTIVITIS 53
628 CYST 53
629 GALLBLADDER DISORDER 53
630 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 53
631 LIVER FUNCTION TEST INCREASED 53
632 BLADDER DISORDER 52
633 BLOOD IRON DECREASED 52
634 BLOOD URINE PRESENT 52
635 HYPOXIA 52
636 RESPIRATORY SYMPTOM 52
637 SQUAMOUS CELL CARCINOMA 52
638 TOOTH FRACTURE 52
639 VITREOUS FLOATERS 52
640 HERNIA 51
641 NOCTURIA 51
642 PROGESTERONE RECEPTOR ASSAY POSITIVE 51
643 SPINAL FRACTURE 51
644 EAR DISCOMFORT 50
645 FEBRILE NEUTROPENIA 50
646 HEPATIC FAILURE 50
647 INCORRECT PRODUCT ADMINISTRATION DURATION 50
648 MUSCULOSKELETAL DISORDER 50
649 QUALITY OF LIFE DECREASED 50
650 SPUTUM INCREASED 50
651 UTERINE LEIOMYOMA 50
652 ANAL INCONTINENCE 49
653 ASCITES 49
654 ASTHENOPIA 49
655 BACK INJURY 49
656 GASTROINTESTINAL PAIN 49
657 HEPATIC NECROSIS 49
658 HYPOAESTHESIA ORAL 49
659 INCORRECT DRUG ADMINISTRATION DURATION 49
660 LABORATORY TEST ABNORMAL 49
661 MENOPAUSE 49
662 PARANOIA 49
663 PERIPHERAL COLDNESS 49
664 SEROTONIN SYNDROME 49
665 VULVOVAGINAL MYCOTIC INFECTION 49
666 VULVOVAGINAL SWELLING 49
667 WEIGHT FLUCTUATION 49
668 ANOSMIA 48
669 APHONIA 48
670 BREAST CANCER IN SITU 48
671 EYE DISCHARGE 48
672 HYPERGLYCAEMIA 48
673 INCONTINENCE 48
674 JOINT DISLOCATION 48
675 NERVE COMPRESSION 48
676 POST-TRAUMATIC STRESS DISORDER 48
677 PRODUCT TASTE ABNORMAL 48
678 PSYCHIATRIC SYMPTOM 48
679 VITAMIN D DECREASED 48
680 APPLICATION SITE URTICARIA 47
681 DRUG ADMINISTRATION ERROR 47
682 EYE INFECTION 47
683 HEMIPARESIS 47
684 HIP ARTHROPLASTY 47
685 IMPAIRED DRIVING ABILITY 47
686 MALNUTRITION 47
687 OBESITY 47
688 PRODUCT FORMULATION ISSUE 47
689 PRODUCT PHYSICAL CONSISTENCY ISSUE 47
690 SEDATION 47
691 SINUSITIS FUNGAL 47
692 VISUAL ACUITY REDUCED 47
693 VULVOVAGINAL INJURY 47
694 BASAL CELL CARCINOMA 46
695 CARDIAC ARREST 46
696 CHOLECYSTECTOMY 46
697 CONCUSSION 46
698 EYE HAEMORRHAGE 46
699 INCREASED TENDENCY TO BRUISE 46
700 INVASIVE DUCTAL BREAST CARCINOMA 46
701 MASS 46
702 PRESCRIBED UNDERDOSE 46
703 SCAB 46
704 SPINAL DISORDER 46
705 DYSMENORRHOEA 45
706 FEELING DRUNK 45
707 GENERALISED TONIC-CLONIC SEIZURE 45
708 HAEMOPTYSIS 45
709 HAIR TEXTURE ABNORMAL 45
710 HEAVY MENSTRUAL BLEEDING 45
711 INCORRECT DOSE ADMINISTERED BY PRODUCT 45
712 LIBIDO DECREASED 45
713 MACULAR DEGENERATION 45
714 MUSCLE ATROPHY 45
715 SECRETION DISCHARGE 45
716 SKIN INFECTION 45
717 AFFECTIVE DISORDER 44
718 APPLICATION SITE HYPERSENSITIVITY 44
719 EXTRA DOSE ADMINISTERED 44
720 FOREIGN BODY SENSATION IN EYES 44
721 HUNGER 44
722 INFUSION SITE HAEMORRHAGE 44
723 LIVER INJURY 44
724 PULMONARY HYPERTENSION 44
725 UTERINE HAEMORRHAGE 44
726 ACCIDENTAL OVERDOSE 43
727 BLOOD TEST ABNORMAL 43
728 CARDIAC FAILURE 43
729 DRUG ABUSE 43
730 HEPATOCELLULAR INJURY 43
731 HYPERAESTHESIA 43
732 INFUSION SITE PRURITUS 43
733 INTENTIONAL OVERDOSE 43
734 ISCHAEMIC STROKE 43
735 MENISCUS INJURY 43
736 MYDRIASIS 43
737 SINUS RHYTHM 43
738 VENTRICULAR EXTRASYSTOLES 43
739 HYPERTRIGLYCERIDAEMIA 42
740 PANCYTOPENIA 42
741 PRESCRIBED OVERDOSE 42
742 SALPINGO-OOPHORECTOMY UNILATERAL 42
743 ULCER 42
744 UPPER-AIRWAY COUGH SYNDROME 42
745 VISUAL FIELD DEFECT 42
746 ANKYLOSING SPONDYLITIS 41
747 BREAST ENLARGEMENT 41
748 FRUSTRATION TOLERANCE DECREASED 41
749 INJURY ASSOCIATED WITH DEVICE 41
750 LOW DENSITY LIPOPROTEIN INCREASED 41
751 LYMPHOCYTE COUNT DECREASED 41
752 NAIL DISORDER 41
753 PRODUCT SUPPLY ISSUE 41
754 SEPTIC SHOCK 41
755 WRIST FRACTURE 41
756 BIPOLAR DISORDER 40
757 COMA 40
758 DELIRIUM 40
759 DENTAL CARIES 40
760 DERMAL ABSORPTION IMPAIRED 40
761 DRY THROAT 40
762 DYSPAREUNIA 40
763 HAEMATOMA 40
764 HELICOBACTER INFECTION 40
765 INFUSION SITE BRUISING 40
766 INTERSTITIAL LUNG DISEASE 40
767 KNEE OPERATION 40
768 LIGAMENT RUPTURE 40
769 MUSCLE SPASTICITY 40
770 MUSCLE STRAIN 40
771 OSTEOMYELITIS 40
772 PHARYNGEAL SWELLING 40
773 PHARYNGITIS 40
774 PHARYNGITIS STREPTOCOCCAL 40
775 PRODUCT LABEL ISSUE 40
776 PULMONARY MASS 40
777 RENAL TUBULAR NECROSIS 40
778 THERAPY CHANGE 40
779 DRUG LEVEL DECREASED 39
780 FOOT DEFORMITY 39
781 MITRAL VALVE INCOMPETENCE 39
782 PLATELET COUNT INCREASED 39
783 PRODUCT DESIGN ISSUE 39
784 SKIN HAEMORRHAGE 39
785 SOMNAMBULISM 39
786 TRANSAMINASES INCREASED 39
787 ABNORMAL FAECES 38
788 BLOOD CREATINE PHOSPHOKINASE INCREASED 38
789 EPIDERMAL NECROSIS 38
790 GRIP STRENGTH DECREASED 38
791 MALIGNANT NEOPLASM PROGRESSION 38
792 NEUROLOGICAL SYMPTOM 38
793 PERICARDITIS 38
794 PSYCHOMOTOR HYPERACTIVITY 38
795 SJOGREN^S SYNDROME 38
796 SPINAL FUSION SURGERY 38
797 BLOOD BILIRUBIN INCREASED 37
798 DIABETIC KETOACIDOSIS 37
799 FORMICATION 37
800 HAEMATEMESIS 37
801 HYPERPARATHYROIDISM SECONDARY 37
802 JOINT RANGE OF MOTION DECREASED 37
803 OSTEONECROSIS OF JAW 37
804 PRODUCT DISTRIBUTION ISSUE 37
805 PRODUCT SIZE ISSUE 37
806 RAYNAUD^S PHENOMENON 37
807 SCRATCH 37
808 THERMAL BURN 37
809 AFFECT LABILITY 36
810 DECREASED INTEREST 36
811 EXPOSURE VIA DIRECT CONTACT 36
812 GLUCOSE TOLERANCE IMPAIRED 36
813 HAEMATURIA 36
814 HALLUCINATION, VISUAL 36
815 LIQUID PRODUCT PHYSICAL ISSUE 36
816 MENSTRUAL DISORDER 36
817 MULTIPLE FRACTURES 36
818 PALLOR 36
819 PLASMA CELL MYELOMA 36
820 RASH MACULO-PAPULAR 36
821 ROSACEA 36
822 SCOLIOSIS 36
823 TOOTH EXTRACTION 36
824 ABSCESS 35
825 APPLICATION SITE DISCOMFORT 35
826 APPLICATION SITE SWELLING 35
827 DIZZINESS POSTURAL 35
828 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35
829 DRUG ERUPTION 35
830 DRY AGE-RELATED MACULAR DEGENERATION 35
831 EYELID PTOSIS 35
832 FRACTURE 35
833 MUSCLE INJURY 35
834 NASAL DISCOMFORT 35
835 NEUTROPHIL COUNT DECREASED 35
836 PERICARDIAL EFFUSION 35
837 PULMONARY FIBROSIS 35
838 SARS-COV-2 TEST POSITIVE 35
839 SKIN WARM 35
840 SPINAL PAIN 35
841 TOOTH LOSS 35
842 CARDIAC FLUTTER 34
843 CENTRAL NERVOUS SYSTEM LESION 34
844 DEEP VEIN THROMBOSIS POSTOPERATIVE 34
845 ENCEPHALOPATHY 34
846 GINGIVAL PAIN 34
847 HEPATITIS 34
848 HYPOCALCAEMIA 34
849 NODULE 34
850 PAROSMIA 34
851 PRODUCT PREPARATION ERROR 34
852 ACUTE RESPIRATORY FAILURE 33
853 BLOOD POTASSIUM INCREASED 33
854 DIARRHOEA HAEMORRHAGIC 33
855 DRUG PRESCRIBING ERROR 33
856 DYSGRAPHIA 33
857 EYELID PAIN 33
858 GINGIVAL BLEEDING 33
859 HERPES SIMPLEX 33
860 IMMUNE SYSTEM DISORDER 33
861 INJECTION SITE IRRITATION 33
862 INTENTIONAL SELF-INJURY 33
863 MADAROSIS 33
864 MAJOR DEPRESSION 33
865 METRORRHAGIA 33
866 POST PROCEDURAL INFECTION 33
867 PULMONARY THROMBOSIS 33
868 RHINITIS ALLERGIC 33
869 SALIVARY HYPERSECRETION 33
870 SINUS TACHYCARDIA 33
871 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 33
872 SNORING 33
873 SWELLING OF EYELID 33
874 TOOTH ABSCESS 33
875 UNRESPONSIVE TO STIMULI 33
876 ADVERSE REACTION 32
877 BLOOD CALCIUM INCREASED 32
878 COVID-19 PNEUMONIA 32
879 DECREASED ACTIVITY 32
880 DERMATITIS ALLERGIC 32
881 FACIAL PARALYSIS 32
882 FOOD ALLERGY 32
883 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32
884 GASTROINTESTINAL INFECTION 32
885 HAIR COLOUR CHANGES 32
886 HYPERCALCAEMIA 32
887 INJECTION SITE HAEMATOMA 32
888 INJECTION SITE INDURATION 32
889 MENORRHAGIA 32
890 POOR VENOUS ACCESS 32
891 SPUTUM DISCOLOURED 32
892 STREPTOCOCCAL INFECTION 32
893 SUSPECTED PRODUCT QUALITY ISSUE 32
894 TONGUE DISCOMFORT 32
895 AMENORRHOEA 31
896 APPLICATION SITE DISCOLOURATION 31
897 CARDIO-RESPIRATORY ARREST 31
898 CIRCULATORY COLLAPSE 31
899 FLANK PAIN 31
900 FULL BLOOD COUNT DECREASED 31
901 HALLUCINATION, AUDITORY 31
902 HAND FRACTURE 31
903 HYPERCHOLESTEROLAEMIA 31
904 LEUKOCYTOSIS 31
905 METABOLIC ACIDOSIS 31
906 ONYCHOCLASIS 31
907 OSTEONECROSIS 31
908 PARKINSON^S DISEASE 31
909 POLYP 31
910 PREGNANCY 31
911 PRODUCT COLOUR ISSUE 31
912 SKIN SWELLING 31
913 SYNOVIAL CYST 31
914 TARDIVE DYSKINESIA 31
915 ADRENAL INSUFFICIENCY 30
916 BREAST SWELLING 30
917 DEMENTIA 30
918 DEVICE USE ERROR 30
919 FOLLICULITIS 30
920 FOOT OPERATION 30
921 GOUT 30
922 HYPERACUSIS 30
923 ILEUS 30
924 LOSS OF LIBIDO 30
925 NASAL DRYNESS 30
926 OBSESSIVE-COMPULSIVE DISORDER 30
927 ORTHOSTATIC HYPOTENSION 30
928 PHOTOPSIA 30
929 POSTOPERATIVE WOUND INFECTION 30
930 ATTENTION DEFICIT HYPERACTIVITY DISORDER 29
931 BUTTERFLY RASH 29
932 CHOLECYSTITIS 29
933 COAGULOPATHY 29
934 HAND DEFORMITY 29
935 HYPERPROLACTINAEMIA 29
936 INABILITY TO AFFORD MEDICATION 29
937 INFUSION SITE DISCHARGE 29
938 INTENTIONAL DRUG MISUSE 29
939 OESOPHAGITIS 29
940 SKIN ABRASION 29
941 SPINAL COMPRESSION FRACTURE 29
942 SQUAMOUS CELL CARCINOMA OF SKIN 29
943 SUNBURN 29
944 ABNORMAL UTERINE BLEEDING 28
945 APPLICATION SITE SCAR 28
946 BODY TEMPERATURE DECREASED 28
947 BREAST CYST 28
948 CLUMSINESS 28
949 CORONARY ARTERY OCCLUSION 28
950 EYE MOVEMENT DISORDER 28
951 HYPERKALAEMIA 28
952 HYPOKINESIA 28
953 INTERVERTEBRAL DISC DISORDER 28
954 MENSTRUATION IRREGULAR 28
955 METASTASES TO LYMPH NODES 28
956 MOUTH SWELLING 28
957 MUSCLE DISORDER 28
958 NIPPLE PAIN 28
959 PANIC REACTION 28
960 PARALYSIS 28
961 PERIORBITAL OEDEMA 28
962 RETINAL VEIN OCCLUSION 28
963 SPONDYLITIS 28
964 TENSION HEADACHE 28
965 VULVOVAGINAL ERYTHEMA 28
966 ARTHROPOD BITE 27
967 BLOOD CALCIUM DECREASED 27
968 BLOOD MAGNESIUM DECREASED 27
969 BREAST DISORDER 27
970 BRONCHOSPASM 27
971 DEVICE RELATED INFECTION 27
972 GASTROINTESTINAL MOTILITY DISORDER 27
973 GLOMERULAR FILTRATION RATE DECREASED 27
974 HAIR DISORDER 27
975 INCORRECT DRUG ADMINISTRATION RATE 27
976 LACERATION 27
977 NECK INJURY 27
978 PELVIC FRACTURE 27
979 PERIORBITAL PAIN 27
980 PRODUCT LEAKAGE 27
981 SUPRAVENTRICULAR TACHYCARDIA 27
982 TEARFULNESS 27
983 TENSION 27
984 THERAPY PARTIAL RESPONDER 27
985 WOUND INFECTION 27
986 ABDOMINAL TENDERNESS 26
987 ACUTE MYOCARDIAL INFARCTION 26
988 APPLICATION SITE INFLAMMATION 26
989 ATROPHIC VULVOVAGINITIS 26
990 BLINDNESS UNILATERAL 26
991 BLOOD THYROID STIMULATING HORMONE INCREASED 26
992 BRAIN NEOPLASM 26
993 CARDIOMYOPATHY 26
994 CEREBRAL HAEMORRHAGE 26
995 EUPHORIC MOOD 26
996 GINGIVAL SWELLING 26
997 GOITRE 26
998 HYPERTENSIVE CRISIS 26
999 IRON DEFICIENCY 26